Related Experiment Video
Updated: Aug 20, 2026
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases
Andreas M Stark1, Kerrin Tongers, Nicolai Maass
1Department of Neurosurgery, University of Schleswig-Holstein Medical Center, Campus Kiel, Schittenhelmstrasse 10, 24105 Kiel, Germany.
Purpose:
Brain metastases are an increasingly common complication in breast cancer patients. The Metastasis Suppressor Genes (MSG) Nm23, KISS1, KAI1, BRMS1, and Mkk4 have been associated with the metastatic potential of breast cancer in vitro and in vivo.
Methods:
The mRNA expression of Nm23, KISS1, KAI1, BRMS1, and Mkk4 in fresh frozen tissue samples of brain metastases from ductal invasive breast cancer specimens was examined in relation to primary tumors. In a first step, mRNA expression screening was carried out using a semi-quantitative RT-PCR approach, in a second step quantitative real-time RT-PCR was performed on selected specimens. By immunohistochemical staining, gene products were visualized on the protein level.
Results:
Semi-quantitative RT-PCR revealed reduced mRNA expression of Nm23, KISS1, KAI1, BRMS, and Mkk4 in brain metastases. Results for KISS1, KAI1, BRMS, and Mkk4 were confirmed by real-time RT-PCR. In detail, mRNA expression reduction in breast cancer brain metastases was tenfold. Expression of MSG could be confirmed by immunohistochemical staining on protein level.
Conclusions:
Our investigations revealed significantly reduced mRNA expression of metastases suppressor genes KISS1, KAI1, BRMS1, and Mkk4 in breast cancer brain metastasis. Particularly, in the case of KISS1 and Mkk4, an important role for future treatment of patients with breast cancer brain metastatic lesions can be assumed.
Insights
Metastasis suppressor genes (MSG) show reduced mRNA expression in breast cancer brain metastases. This finding is crucial for understanding and treating brain metastatic lesions in breast cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Brain metastases are a growing concern in breast cancer care.
- Metastasis Suppressor Genes (MSG) like Nm23, KISS1, KAI1, BRMS1, and Mkk4 are implicated in breast cancer metastasis.
Purpose of the Study:
- To investigate the mRNA expression of specific metastasis suppressor genes in breast cancer brain metastases.
- To compare gene expression in metastatic tissue with primary tumors.
Main Methods:
- Utilized semi-quantitative and quantitative real-time RT-PCR to analyze mRNA expression of Nm23, KISS1, KAI1, BRMS1, and Mkk4.
- Employed immunohistochemical staining to validate protein expression levels.
Main Results:
- Demonstrated significantly reduced mRNA expression of Nm23, KISS1, KAI1, BRMS1, and Mkk4 in brain metastases compared to primary tumors.
- Observed a tenfold reduction in mRNA expression for these genes in metastatic lesions.
- Confirmed protein expression of these metastasis suppressor genes via immunohistochemistry.
Conclusions:
- Breast cancer brain metastases exhibit significantly lower mRNA expression of KISS1, KAI1, BRMS1, and Mkk4.
- KISS1 and Mkk4 show particular promise for future therapeutic strategies in treating breast cancer brain metastases.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs